START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Clinical trial NCT05492682 · RECRUITING

Trial details

NCT number: NCT05492682
Sponsor: Valo Therapeutics Oy
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)Triple-Negative Breast Cancer Non-Small Cell Lung Cancer Synovial Sarcoma Myxoid Liposarcoma Colorectal Cancer Osteosarcoma Sarcoma

Start date: 2023-02-02
Primary completion: 2027-04-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.